Status:
UNKNOWN
Rocuronium and Supramaximal Stimulation
Lead Sponsor:
Taipei Medical University Hospital
Conditions:
Neuromuscular Blockade
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To shorten induction time, some anesthesiologist gives a priming dose of muscle relaxant before starting Neuromuscular Transmission monitor (NMT). To properly evaluate neuromuscular function during th...
Detailed Description
The NMT monitor module automatically determines the current needed for the supramaximal stimulus, and maintains this current throughout the procedure. The supramaximal current is the current above wh...
Eligibility Criteria
Inclusion
- Patients receiving general anesthesia and use rocuronium for induction
Exclusion
- Muscular disease
- Peripheral neuropathy
- Difficult airway or difficult mask ventilation
- Allergy to study related medication
- Pregnant woman
- \< 20-year-old or \> 65-year-old
- BMI \<18.5 or BMI\>24.9
Key Trial Info
Start Date :
December 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05294523
Start Date
December 20 2021
End Date
December 31 2024
Last Update
November 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University Hospital
Taipei, Taiwan, 220